Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.
    Difference
    3%
    Check dated 2025-10-06T05:21:54.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; Back to Top removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:57:14.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T14:15:15.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated to include new publications related to pembrolizumab and neoplastic processes, while several location-related terms and some previous content about lung cancer and immunological agents have been removed.
    Difference
    8%
    Check dated 2025-08-31T11:42:30.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:38:12.000Z thumbnail image

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.